Evaluation of OE-MRI in patients with H&N cancer

  • Research type

    Research Study

  • Full title

    Evaluation of Oxygen Enhanced MRI for Identification of Hypoxia Induced Resistant Tumours in Patients with Head and Neck Cancer

  • IRAS ID

    290288

  • Contact name

    Rafal Panek

  • Contact email

    rafal.panek@nuh.nhs.uk

  • Sponsor organisation

    Nottingham University Hospitals NHS trust

  • Clinicaltrials.gov Identifier

    NCT04724096

  • Duration of Study in the UK

    2 years, 0 months, 1 days

  • Research summary

    Patients with head and neck cancer are treated using a combination of chemotherapy, radiotherapy (CRT) and surgical treatment. Tumour response to CRT varies greatly. Some tumours completely respond to the treatment and others do not respond at all.

    Magnetic Resonance Imaging (MRI) provides excellent visualisation of tumours and vital adjacent organs. This allows for very accurate identification of tumour volumes requiring radiotherapy treatment and the normal tissues that need to be avoided. MRI scans are routinely used to diagnose head and neck patients and their response to treatment.

    The unique ability of MRI is to provide information on biology and function of tissues, including oxygen delivery. This can be achieved comparing images acquired whilst breathing air versus pure oxygen.

    We propose to use this method to assess tumour oxygenation in head and neck cancers and detect areas of poor oxygenation, which are less likely to respond to standard radiotherapy treatment. This would allow better personalising of the radiotherapy treatment plan and potentially improve the outcome for these patients in the future.

    This feasibility study will involve the recruitment of 50 patients at NUH who will be scanned whilst breathing oxygen in addition to their routine MRI scan. 5 healthy volunteers will also be scanned to validate the protocol before patient scans.

    Research Summary:
    Evaluation of Oxygen Enhanced Magnetic Resonance Imaging for Identification of Hypoxia Induced Resistant Tumours in Patients with Head and Neck Cancer.

  • REC name

    South Central - Berkshire Research Ethics Committee

  • REC reference

    21/SC/0050

  • Date of REC Opinion

    9 Feb 2021

  • REC opinion

    Favourable Opinion